CUSP Comments on Continued Misapplication of Opioid Prescribing Guidelines
January 20, 2025
CUSP urges CDC to address misinterpretations of the opioid prescribing guideline and take corrective action.
Media
Institute Launches Nat’l Recovery Friendly Workplace Certification
May 28, 2024
The National Recovery Friendly Workplace Institute has created a national Recovery Friendly Workplace certification program for employers.
CUSP Supports FDA Data Improvement Plan
January 18, 2024
CUSP sends letter supporting FDA’s plan to improve substance misuse data collection, highlighting the crucial role of the RADARS System in addressing substance misuse.
Collaborating Organizations
Engage
Last week, the FDA approved the first new pain reliever in 20+ years. This non-opioid targets sodium channels to treat acute pain. While trials showed its effectiveness in post-surgical patients, its benefits for chronic pain may be limited. Learn more:
Tomorrow, our Chairman @MCBtweets will moderate a Congressional briefing on enhancing decision-making and patient outcomes with AI, featuring policymakers, physicians, tech innovators, and patient care advocates. RSVP here:
In response to an activist group opposing FDA funding for a substance misuse surveillance program, CUSP sent FDA a letter underscoring RADARS System's role in researching and responding to medication diversion, substance misuse, and addiction. Read letter:
Thank you @GovKathyHochul for signing S2677/A463 to help ensure patients get the information they need when faced with a denial due to #steptherapy. Thank you @NeilBreslin46 and @johnmcdonald108 for your leadership! #HappyHolidays